EN
EN
FR
ES
PT
AR
RU
DE
IT
NL
TH
KO
VI
ID
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us
NEWS AND INFORMATION
Home
/
News
/
News and information
/
Kexing Biopharm...
Kexing Biopharm's Product List (FDA and EMA Approved)
Article source：Kexing Biopharm
Jun 17,2025
View： 1812
LABEL:
< Harnessing the Power of Recombinant Collagen Repair Mask for Youthful Skin
Kexing Biopharm's Product Introduction >
BACK TO LIST
Related News
Oct 20,2023
The Importance of Choosing a Reliable Human Erythropoietin Injection Manufacturer
READ MORE >>
Jul 13,2023
China's first infliximab biosimilar drug ready for export, Kexing Biopharm initiated drug registration in 17 countries
READ MORE >>
Nov 05,2024
Recombinant Collagen Anti-Wrinkle Single Use Essence: Innovative Approach to Skincare
READ MORE >>
Oct 09,2023
Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery
READ MORE >>
Sep 08,2023
Unlocking the Power of Albumin-Bound Paclitaxel: Quality, Affordability, and Innovation
READ MORE >>
Sep 20,2023
Exploring the Power of Albumin-Bound Paclitaxel: A Breakthrough in Cancer Treatment
READ MORE >>
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us
Article source：Kexing Biopharm
Jun 17,2025
View：
1812 
BACK TO LIST
Oct 20,2023
